# Methylphenidate for Apathy in Veterans With Parkinson's Disease

> **NCT05669170** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Ralph H. Johnson VA Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Parkinson Disease
- Apathy

## Interventions

- **BEHAVIORAL:** Psychosocial intervention
- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT05669170
- **Lead sponsor:** Ralph H. Johnson VA Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01
- **Primary completion:** 2027-12
- **Final completion:** 2028-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05669170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05669170, "Methylphenidate for Apathy in Veterans With Parkinson's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05669170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*